188 results on '"Karadurmus, N."'
Search Results
2. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience
3. 702P Survival and related factors in testicular non-seminomatous patients undergoing high-dose chemotherapy and autologous stem cell transplantation: Experience of Turkey's highest volume transplantation center
4. First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis
5. P-90 First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis
6. P-92 Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study
7. Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
8. Oxidative stress status and plasma trace elements in patients with asthma or allergic rhinitis
9. Oxidative stress status in patients with chronic idiopathic urticaria
10. 120O Pembrolizumab (Pembro) with or without lenvatinib (Lenva) in first-line metastatic NSCLC with PD-L1 TPS ≥1% (LEAP-007): A phase III, randomized, double-blind study
11. Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study
12. Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study
13. The 30-day mortality rate after first cycle of immunotherapy
14. 443P Efficacy and safety of CDK 4/6 inhibitors in patients with bone marrow-involved metastatic breast cancer
15. 1720P Experience in the provision of oncology services immediately after a major disaster
16. Comparison of lymphomononuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients
17. NAUSEA PROFILE ACCORDING TO CONDITIONING REGIMENS IN CANCER PATIENTS UNDERWENT HIGH DOSE CHEMOTHERAPY AND STEM CELL TRANSPLANTATION: PH-AB090
18. HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION OF HEMATOLOGICAL MALIGNANCIES IN GATA TRANSPLANT CENTER: A SINGLE-CENTER EXPERIENCE: PH-AB091
19. BRENTUXIMAB VEDOTIN (SGN-35) IN HODGKIN LYMPHOMA PATIENTS WITH RELAPSED AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM-CELL TRANSPLANTATION: PH-AB018
20. The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study
21. Palliative Care, and Oncologists (ARES Study): a Study of the Palliative
22. Does primary tumor localization has prognostic importance in seminoma patients?: Turkish oncology Group study
23. patients?: Turkish Oncology Group Study
24. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience [2]
25. experience
26. 99P The association between antibiotic use and survival in renal cell carcinoma patients treated with nivolumab: A multi-center study
27. Crizotinib efficacy in alk-positive advanced stage non-small cell lung cancer patients: A real-world experience from Turkey
28. metastatic, trastuzumab-naive breast cancer: real-life practice outcomes
29. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes
30. PS1245 NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI-CENTER EXPERIENCE IN TURKEY
31. 976P The 30-day mortality rate after first cycle of immunotherapy
32. P-219 Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study
33. NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY
34. experience
35. P126 - The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study
36. A Very Rare Case – Hairy Cell Leukemia in Patient with Sarcoidosis
37. Erratum to: Comparison of lymphomononuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients
38. P-209 Multicenter real life experience of biological agents in patients with metastatic colorectal cancer
39. Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey
40. 985P - The effects of primary testicular tumour localization on prognosis in patients with nonseminomatous testis cancer
41. An elderly diabetic case of ochronosis with depression and chronic pain
42. Comparison of lymphomononuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients (vol 37, pg 135, 2010)
43. Transforming growth factor ? (TGF-?) levels in otherwise healthy subjects with impaired glucose tolerance
44. PP-082 DELAYED ENGRAFTMENT DUE TO CANDIDA NORVEGENSIS IN HDC AND SCT PATIENT
45. PP-120 HIGH DOSE CHEMOTHERAPY IN PATIENTS WITH MANTLE CELL LYMPHOMA
46. PP-077 TREATMENT OF HIGH RISK EWING’S SARCOMA WITH HDC AND SCT
47. PP-084 THE OUTCOME OF HDC AND ASCT IN PATIENTS WITH RECURRENT MEDULLOBLASTOMA
48. PP-076 A CASE OF RELAPSED HODGKIN’S LYMPHOMA IDENTIFIED AFTER 20 YEARS
49. PP-083 SECONDARY ALL IN MULTIPLE MYELOMA PATIENT WHO UNDERWENT HDC AND SCT
50. Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.